A detailed history of First Republic Investment Management, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 21,422 shares of CTLT stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,422
Holding current value
$1.27 Million
% of portfolio
0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$44.2 - $50.2 $946,852 - $1.08 Million
21,422 New
21,422 $975,000
Q1 2023

May 11, 2023

BUY
$45.44 - $74.26 $3 Million - $4.9 Million
65,940 Added 171.68%
104,348 $6.86 Million
Q4 2022

Feb 13, 2023

SELL
$41.39 - $81.0 $1.05 Million - $2.06 Million
-25,487 Reduced 39.89%
38,408 $1.73 Million
Q3 2022

Nov 03, 2022

BUY
$72.36 - $113.1 $248,556 - $388,498
3,435 Added 5.68%
63,895 $4.62 Million
Q2 2022

Aug 16, 2022

BUY
$87.2 - $114.05 $51,709 - $67,631
593 Added 0.99%
60,460 $6.49 Million
Q1 2022

May 16, 2022

BUY
$94.19 - $124.49 $3.63 Million - $4.79 Million
38,488 Added 180.03%
59,867 $6.64 Million
Q4 2021

Feb 09, 2022

BUY
$119.57 - $139.07 $86,807 - $100,964
726 Added 3.52%
21,379 $2.74 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $788,425 - $1.03 Million
-7,222 Reduced 25.91%
20,653 $2.75 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $1.02 Million - $1.17 Million
10,120 Added 57.0%
27,875 $3.01 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $521,456 - $643,511
-5,137 Reduced 22.44%
17,755 $1.87 Million
Q4 2020

Feb 16, 2021

SELL
$85.88 - $105.36 $2,318 - $2,844
-27 Reduced 0.12%
22,892 $2.38 Million
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $238,950 - $303,862
-3,285 Reduced 12.54%
22,919 $1.96 Million
Q2 2020

Aug 13, 2020

SELL
$48.02 - $79.04 $156,449 - $257,512
-3,258 Reduced 11.06%
26,204 $1.92 Million
Q1 2020

May 13, 2020

BUY
$36.95 - $62.95 $1.09 Million - $1.85 Million
29,462 New
29,462 $1.53 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.